• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逐片构建心脏:心脏组织工程的现状

Engineering the heart piece by piece: state of the art in cardiac tissue engineering.

作者信息

Hecker Louise, Birla Ravi K

机构信息

Cell and Developmental Biology, The University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Regen Med. 2007 Mar;2(2):125-44. doi: 10.2217/17460751.2.2.125.

DOI:10.2217/17460751.2.2.125
PMID:17465746
Abstract

According to the National Transplant Society, more than 7000 Americans in need of organs die every year owing to a lack of lifesaving organs. Bioengineering 3D organs in vitro for subsequent implantation may provide a solution to this problem. The field of tissue engineering in its most rudimentary form is focused on the developed of transplantable organ substitutes in the laboratory. The objective of this article is to introduce important technological hurdles in the field of cardiac tissue engineering. This review starts with an overview of tissue engineering, followed by an introduction to the field of cardiovascular tissue engineering and finally summarizes some of the key advances in cardiac tissue engineering; specific topics discussed in this article include cell sourcing and biomaterials, in vitro models of cardiac muscle and bioreactors. The article concludes with thoughts on the utility of tissue-engineering models in basic research as well as critical technological hurdles that need to be addressed in the future.

摘要

根据国家移植协会的数据,每年有超过7000名需要器官移植的美国人因缺乏救命器官而死亡。在体外生物工程制造3D器官以供后续植入可能为这个问题提供解决方案。组织工程领域最基本的形式专注于在实验室中开发可移植的器官替代品。本文的目的是介绍心脏组织工程领域的重要技术障碍。这篇综述首先概述组织工程,接着介绍心血管组织工程领域,最后总结心脏组织工程的一些关键进展;本文讨论的具体主题包括细胞来源和生物材料、心肌的体外模型以及生物反应器。文章最后思考了组织工程模型在基础研究中的效用以及未来需要解决的关键技术障碍。

相似文献

1
Engineering the heart piece by piece: state of the art in cardiac tissue engineering.逐片构建心脏:心脏组织工程的现状
Regen Med. 2007 Mar;2(2):125-44. doi: 10.2217/17460751.2.2.125.
2
Cardiac tissue engineering: state of the art.心脏组织工程学:最新进展。
Circ Res. 2014 Jan 17;114(2):354-67. doi: 10.1161/CIRCRESAHA.114.300522.
3
Tissue engineering: The beat goes on.组织工程学:蓬勃发展。
Nature. 2003 Feb 27;421(6926):884-6. doi: 10.1038/421884a.
4
Cell sheet transplantation for heart tissue repair.细胞片层移植用于心脏组织修复。
J Control Release. 2013 Aug 10;169(3):336-40. doi: 10.1016/j.jconrel.2013.03.003. Epub 2013 Mar 14.
5
Meeting the needs of monitoring in tissue engineering.满足组织工程中的监测需求。
Regen Med. 2007 Mar;2(2):145-60. doi: 10.2217/17460751.2.2.145.
6
Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro.鼠源和人源多能干细胞来源的拟胚体可在体外形成收缩性心肌组织。
Eur Heart J. 2013 Apr;34(15):1134-46. doi: 10.1093/eurheartj/ehs349. Epub 2012 Oct 26.
7
Cell sheet-based cardiac tissue engineering.基于细胞片层的心脏组织工程。
Anat Rec (Hoboken). 2014 Jan;297(1):65-72. doi: 10.1002/ar.22834. Epub 2013 Dec 2.
8
Fibrin as a scaffold for cardiac tissue engineering.纤维蛋白作为心脏组织工程的支架。
Biotechnol Appl Biochem. 2011 Sep-Oct;58(5):301-10. doi: 10.1002/bab.49. Epub 2011 Oct 5.
9
Vascularisation to improve translational potential of tissue engineering systems for cardiac repair.血管化以提高用于心脏修复的组织工程系统的转化潜力。
Int J Biochem Cell Biol. 2014 Nov;56:38-46. doi: 10.1016/j.biocel.2014.10.020. Epub 2014 Oct 23.
10
Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.细胞治疗、3D 培养系统和组织工程学在心脏再生中的应用。
Adv Drug Deliv Rev. 2014 Apr;69-70:254-69. doi: 10.1016/j.addr.2013.12.004. Epub 2013 Dec 27.

引用本文的文献

1
Bioengineering Cardiac Tissue Constructs With Adult Rat Cardiomyocytes.用成年大鼠心肌细胞构建生物工程心脏组织。
ASAIO J. 2018 Sep/Oct;64(5):e105-e114. doi: 10.1097/MAT.0000000000000765.
2
Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.在组织工程心脏构建物中建立早期功能性灌注和结构
Crit Rev Biomed Eng. 2015;43(5-6):455-71. doi: 10.1615/CritRevBiomedEng.2016016066.
3
Development of a Cyclic Strain Bioreactor for Mechanical Enhancement and Assessment of Bioengineered Myocardial Constructs.
用于机械增强和评估生物工程心肌构建体的循环应变生物反应器的开发。
Cardiovasc Eng Technol. 2015 Dec;6(4):533-45. doi: 10.1007/s13239-015-0236-8. Epub 2015 Jul 24.
4
Stem cell therapy and tissue engineering for correction of congenital heart disease.干细胞治疗和组织工程学纠正先天性心脏病。
Front Cell Dev Biol. 2015 Jun 30;3:39. doi: 10.3389/fcell.2015.00039. eCollection 2015.
5
Modulation of the cardiomyocyte contraction inside a hydrostatic pressure bioreactor: in vitro verification of the Frank-Starling law.流体静压生物反应器中心肌细胞收缩的调节:Frank-Starling定律的体外验证
Biomed Res Int. 2015;2015:542105. doi: 10.1155/2015/542105. Epub 2015 Jan 15.
6
Epithelial machines of morphogenesis and their potential application in organ assembly and tissue engineering.形态发生的上皮机器及其在器官组装和组织工程中的潜在应用。
Biomech Model Mechanobiol. 2012 Nov;11(8):1109-21. doi: 10.1007/s10237-012-0423-6. Epub 2012 Aug 2.
7
Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.细胞疗法治疗心脏功能恢复:关注心肌组织工程和纳米技术。
Cardiol Res Pract. 2012;2012:971614. doi: 10.1155/2012/971614. Epub 2012 Apr 22.
8
Intangible factors leading to success in research: strategy, innovation and leadership.导致研究成功的无形因素:策略、创新和领导力。
J Cardiovasc Transl Res. 2008 Mar;1(1):85-92. doi: 10.1007/s12265-007-9000-2. Epub 2008 Feb 8.
9
Variable optimization for the formation of three-dimensional self-organized heart muscle.三维自组织心肌形成的变量优化。
In Vitro Cell Dev Biol Anim. 2009 Dec;45(10):592-601. doi: 10.1007/s11626-009-9234-1. Epub 2009 Sep 15.
10
Effect of streptomycin on the active force of bioengineered heart muscle in response to controlled stretch.链霉素对生物工程心肌在受控拉伸时主动力的影响。
In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):253-60. doi: 10.1007/s11626-008-9114-0. Epub 2008 Jun 21.